back to Directory

Atomic AI

Atomic AI logo

Founded
2020

Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people.


Posts Mentioning This Company

19 Companies Pioneering AI Foundation Models in Pharma and Biotech

  
Foundation models represent a new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. As these models grow increasingly capable, they become useful for applications across a wide range of economic functions and industries, including biotech. Foundation models are a class of large-scale machine learning …

7 Promising RNA Biotech Companies To Watch in 2024

  
For many years the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there is a completely different level of cell regulation – transcriptome level, presented by Ribonucleic acids (RNAs). RNA molecules are not just intermediates between DNA and proteins, in fact, they also carry …

14 Cutting-Edge Startups Focusing On RNA Research

  
For many years, the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there is a completely different level of cell regulation: the transcriptome level, presented by ribonucleic acids (RNAs).

The Growing Momentum for AI Foundation Models in Biotech and 12 Notable Companies

  
As artificial intelligence (AI) foundation models grow increasingly capable, they become useful for applications across a wide range of economic functions and industries, including biotech. The most prominent examples of general purpose foundation models are the GPT-3 and GPT-4 models, which form the basis of ChatGPT, and BERT, or Bidirectional …

11 Biopharma Trends to Watch in 2024

  
2023 has marked a remarkable year of technological advancements in drug discovery and biotechnology. Ironically, the elation from a kaleidoscope of technological and scientific advances is in stark contrast with the overall industry’s economic performance—it was also a rough year for biopharma overall. There are signs that 2024 might be better …

9 Innovative Life Sciences Companies to Watch in 2024

  
The biotech and pharmaceutical industries are entering 2024 amid a wave of innovation and technological advancement.  The biopharma field is increasingly influenced by the advent of cutting-edge technologies such as artificial intelligence (AI), organ-on-a-chip systems, and gene editing therapies promising more personalized and precise treatments for a variety of conditions.